infection. An observational study of 337 women was conducted to evaluate a new polymerase chain reaction (PCR) test for TV. The sensitivities of wet preparation and TV culture were 52% (95% confidence interval [CI], 41-62) and 78% (95% CI, 69-86), respectively. TV PCR had a sensitivity of 84% (95% CI, 75-90) and a specificity of 94% (95% CI, 90-97). Metronidazole was provided to 67 (69%) of 97 women with TV because of TV on wet preparation, exposure to TV, or a diagnosis of bacterial vaginosis or pelvic inflammatory disease; however, if TV PCR had been used for diagnosis, 81 (84%) of 97 women with TV would have been treated ( ). TV is significantly P p .02 undertreated using standard algorithms for metronidazole therapy. Given the association of trichomoniasis with perinatal morbidity and HIV transmission, women in high-risk groups may benefit from TV PCR.
metronidazole treatment of pregnant women with asymptomatic TV infection paradoxically increased rates of preterm delivery [6] . Alternatively, treatment of TV infection in HIV-infected women has been shown to decrease vaginal HIV RNA levels [4] , and vaginal HIV RNA levels are associated with the risk of perinatal HIV transmission [7, 8] . Treating symptomatic and asymptomatic TV infection would likely lower the overall prevalence of disease, but more research will be needed to clarify the impact of metronidazole treatment on the prevention of TV-related morbidity.
Presently, the greatest impediment to effective treatment of TV infection is the low sensitivity of the most commonly used diagnostic test, wet preparation [9] . PCR has recently emerged as a potentially powerful tool for TV diagnosis with high sensitivity and specificity [10] [11] [12] [13] . However, PCR testing is expensive, and, to our knowledge, no study has evaluated its impact on clinical practice. Although TV PCR may increase diagnostic sensitivity, it may not result in a significantly greater number of patients with TV infection who are treated. Current Centers for Disease Control and Prevention guidelines for STD treatment recommend metronidazole therapy not only for patients with TV infection diagnosed by wet preparation but also for patients with a history of exposure to a TV-infected partner. Metronidazole is also recommended as a therapeutic option for patients with a clinical diagnosis of bacterial vaginosis (BV) or pelvic inflammatory disease [14] . Amsel criteria for BV diagnosis have significant overlap with the clinical findings in TV infection and may facilitate the treatment of TV infection in women with a false-negative finding on wet preparation [15] .
This study evaluated the prevalence of TV infection in a high-risk cohort and compared the reliability of wet preparation, culture for TV, and TV PCR. The number of patients with TV infection who received metronidazole treatment under current clinical algorithms was compared with the projected number who would receive treatment if TV PCR were used for diagnosis.
PATIENTS AND METHODS
The institutional review boards of the Johns Hopkins Medical Institutions and the Baltimore City Health Department (Maryland) approved this study. Analysis was retrospective, and PCR was performed after all personal identifiers had been removed from samples and new, unique identifiers had been assigned.
Women attending a Baltimore City Health Department STD clinic were evaluated from March through July 2000. Any woman attending the STD clinic was eligible. Women who had received antibiotic therapy within the 2 weeks before their visit were excluded from the study.
Patient information was collected on a standardized medical record form. Clinicians recorded information about age, sex, genitourinary symptoms, STD history, menstrual history, contraceptive history, sexual behavior, results of previous HIV tests, and drug and alcohol use. Each patient underwent physical examination, including examination of the external genitalia and speculum-assisted and bimanual examination.
Clinical laboratory evaluation. Laboratory evaluation included measurement of vaginal pH; amine test; potassium hydroxide wet mount microscopic examination for detection of yeast; wet preparation for microscopic detection of TV and clue cells; TV culturing using the InPouch TV test (Biomed Diagnostics); cervical swabs for Gram stain, gonorrhea culture, and chlamydia PCR; and Papanicolaou smear. Vaginal swabs stored in PCR buffer at -30ЊC were retrospectively analyzed with TV PCR.
Swab specimens from the posterior fornix of the vagina were mixed in 2-3 drops of normal saline and then placed on a slide for microscopic examination. Slides were evaluated at magnifications of ϫ100 and ϫ400 for evidence of clue cells or motile TV. Specimens from the posterior fornix of the vagina were obtained by swab and inoculated directly into an InPouch TV test for culture for TV. The pouches were incubated at 37ЊC in a 5% CO 2 incubator. Direct microscopic examination of the plastic pouch was performed at 24 h, and, if the results were negative, evaluation was repeated at 48 h and at 5 days.
Endocervical swab specimens were used for Gram stain preparation and inoculation of culture plates. Gram stains were assessed at a magnification of ϫ1000 under oil immersion for polymorphonuclear cell counts and the presence of intracellular gram-negative diplococci. Thayer-Martin culture plates were incubated at 35ЊC in a 5% CO 2 incubator. A second endocervical swab was placed in PCR buffer and tested by use of chlamydia PCR (Amplicor; Roche Diagnostic Systems), according to the manufacturer's directions. Finally, ectocervical and endocervical samples were obtained with an Ayre spatula and endocervical brush and fixed on a clear glass slide. These Papanicolaou smears were evaluated by a pathologist.
TV PCR. Stored vaginal samples were processed by TV PCR after removal of patient identifiers and labeling with study identification numbers. Results of TV PCR analysis were retrospectively compared with the results of wet preparation and the InPouch TV test. Vaginal swabs in commercial PCR buffer (Amplicor) were stored at -30ЊC and processed in batches. After thawing, 100 mL of sample was processed with Amplicor specimen buffers. The PCR primer set BTUB 9/2 was used to target 112-bp conserved regions of the 3 b-tubulin genes of TV [12] . The final reaction mixture (100 mL) contained 10 mL of sample, 10 mL of 10ϫ PCR buffer, 25 pmol of each primer, 2.5 mM of each of 4 deoxynucleoside triphosphates (ATP, CTP, GTP, and TTP), 10 mL of bentadine solution (Q solution), 2.5 mM of magnesium chloride, and 2.5 U of DNA polymerase (Qiagen HotStarTaq DNA Polymerase). Positive and negative controls were included in every run, and PCR setup and thermocycling/detection protocols were performed in separate rooms with dedicated pipettes and aerosol barrier pipette tips. A touchdown method of thermal cycling was used with a total of 60 cycles [12] . Amplified product was electrophoresed at 120 V in 3% agarose gels in Tris-borate-EDTA buffer and stained with ethidium bromide (0.01 mM). Product size was compared with commercial markers. Discordant results between BTUB 9/2 TV PCR and TV cultures were adjudicated with primer sets TVK 3/7 and AP65 A/B [12, 16] .
Definitions. True positive trichomoniasis was defined as the presence of motile TV on wet preparation, a positive InPouch TV test result, or a positive TV PCR with BTUB 9/2 confirmed by PCR with primers TVK 3/7 or AP65 A/B. TV on 
was considered to be statistically sig-P ! .05 nificant. Multiple logistic regression was used to determine epidemiologic and clinical factors associated with TV diagnosis. Multiple logistic regression model fit was assessed with Pearson's goodness-of-fit test. The sensitivity and specificity of diagnostic methods for TV were calculated with true positive trichomoniasis, as defined above.
RESULTS
During a 5-month period, 361 consecutive women were evaluated using the InPouch TV test. After the exclusion of 24 women who did not have samples for TV PCR, a total of 337 women were included in the study. Ninety-eight percent of the women were African American, and the mean age was 28 years (range, 14-58 years; ). Multivariate analysis also dem-P ! .01 ; table 4 ). Of the 30 patients who did P p .02 not receive treatment at their first visit, 13 patients had culture results positive for TV and were contacted for treatment. Of the remaining 17 patients who did not receive metronidazole therapy and who were TV PCR positive but culture negative, 10 patients were not treated, did not have reported symptoms at follow-up, and did not subsequently receive a diagnosis of or treatment for TV infection; 5 patients had no available follow-up data; 1 patient was evaluated 8 days after initial evaluation and found to have negative results of culture and PCR for TV; and 1 patient was seen 3 months after initial evaluation and found to have a positive result of wet preparation for TV.
DISCUSSION
This study evaluated TV infection in women at significant risk for TV-related morbidity. TV was the most prevalent STD in the cohort (in 29% of subjects), and it was the only STD that was found in HIV-infected women. In this STD setting, older age, active drug use, and abnormal vulvovaginal discharge at the time of the examination were associated with a diagnosis of TV infection. A history of chlamydia was independently associated with a lower prevalence of TV infection. The reason for this association is unclear, but a possible explanation would include a switch to safer sexual practices after receiving a diagnosis of chlamydia. Alternatively, a previous diagnosis of chlamydia may be a marker of past gynecologic evaluation with associated metronidazole treatment.
Although wet preparation is the only test widely available in most STD clinics, its sensitivity was poor. Culture for TV is a relatively inexpensive option, but it requires rapid sample transport or on-site incubation. Culture is also time-consuming, requiring up to 5-7 days to obtain complete results. In this study, PCR reliability was lower than previously reported [12, 13] . This may in part have been the result of the retrospective testing of samples, which necessitated freezing and extended storage. Despite these limitations, PCR sensitivity exceeded that of wet preparation and culture, and its specificity was high.
Diagnosis of TV infection by means of wet preparation, treatment of known recent contacts of TV infection, and treatment algorithms recommending metronidazole use for conditions including BV and pelvic inflammatory disease resulted in the treatment of only 69% of TV-infected women. The use of TV PCR would have allowed treatment of 84% of TV-infected women ( ). Results of passive follow-up in this study P p .02 suggest that clinical reevaluation does not reliably lead to diagnosis or treatment of occult TV infection. TV PCR would improve identification and treatment of symptomatic and asymptomatic TV infection and could prove to be an invaluable tool in decreasing the prevalence of infection. Although 1 trial failed to show improvements in pregnancy outcomes after treatment for TV, preliminary data suggest that treatment of TV infection in HIV-infected women may reduce vaginal HIV RNA levels, which could have important implications for perinatal HIV transmission [4, [6] [7] [8] . Further research is needed to fully define the clinical benefits that would be associated with improved detection and treatment of TV infection. The primary limitations of this study are the retrospective application of TV PCR on stored, frozen samples and the cross-sectional design of the study. Prospective application of TV PCR in selected high-risk populations is needed to determine whether targeted testing will be clinically useful and financially feasible. Further investigation must also determine whether improved diagnosis of TV infection will not only facilitate its appropriate treatment but also decrease its associated morbidity.
